Funding Opportunity: NIGMS Technology Research and Development
We’ve just re-issued two funding
opportunity announcements (FOAs) for technology research and development grants
that support biomedical
research areas within the NIGMS
mission.
They are:
Exploratory Research for Technology Development (R21) PAR-19-254 Two-year grants that support innovative, high-risk concepts for developing a new technology or radically improving an existing one. The R21 supports only novel concepts that haven’t yet been tested for feasibility. Thus, unpublished data are not allowed. Because proof of concept must not already be developed, NIGMS expects the projects to be high risk.
Next application receipt
date: June 16, 2019
Focused Technology Research and Development (R01) PAR-19-253 Four-year grants that support development projects to validate and optimize a new technology. The R01 is for technologies that already have been shown to be feasible but need further technical work to produce a useful prototype. Projects with partial demonstration of feasibility but with substantial risk remaining could be submitted as a 3-year R01 with a reduced budget under this FOA.
Next
application receipt date: June 5, 2019
For both the R21 and R01
programs, we’re seeking inventive technology that significantly advances the state
of the art. Examples would include instruments, devices, processes, algorithms,
software, chemicals, biomolecules, or cells that have potential value for enabling
new basic biomedical research. Applicants s...
Source: NIGMS Feedback Loop Blog - National Institute of General Medical Sciences - Category: Biomedical Science Authors: Chrissa Chverchko Tags: Funding Opportunities Biomedical Technology Source Type: blogs
More News: Biomedical Science | Blogging | Budgets | Chemistry | Funding | Grants | Learning | Universities & Medical Training